Author:
Limouris Georgios S.,Chatziioannou Achilles,Kontogeorgakos Dimitrios,Mourikis Dimitrios,Lyra Maria,Dimitriou Panagiotis,Stavraka Anastasia,Gouliamos Athanassios,Vlahos Lambros
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine
Reference50 articles.
1. Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol. 1999;20:157–98.
2. Janson ET, Westlin J-E, Öhrvall U, Öberg K, Lukinius A. Nuclear localization of 111In after intravenous injections of [111In-DTPA-d-Phe1]-octreotide in patients with neuroendocrine tumors. J Nucl Med. 2000;41:1514–8.
3. Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WA, Kooij PP, Oei HY, et al. Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med. 1993;20:716–31.
4. De Jong M, Bernard BF, De Bruin E, Van Gameren A, Bakker WH, Visser TJ, et al. Internalization of radiolabelled [DTPA°]octreotide and [DOTA°, Tyr3]octreotide: peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy. Nucl Med Commun. 1998;19:283–8.
5. Anderson P, Forssel-Aronsson E, Johanson V, Wängberg B, Nilsson O, Fjälling M, et al. Internalization of indium-111 into human neuroendocrine tumor cell after incubation with indium-11-DTPA-d-Phe1-octreotide. J Nucl Med. 1996;37:2002–6.
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献